Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate + PD-1 + Radiotherapy in Solid Tumors
NCT05522582Phase 2Active, not recruiting
- Sponsor
- Yancheng First People's Hospital
- Start
- Nov 2021
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate in solid tumor, sponsored by Yancheng First People's Hospital. Started Nov 2021; status: active, not recruiting.
02
Drugs
methotrexate
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05522582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05522582.